| Literature DB >> 33913001 |
Antonia Perju1, Nongnoot Wongkaew2.
Abstract
Lateral flow assays (LFAs) are the best-performing and best-known point-of-care tests worldwide. Over the last decade, they have experienced an increasing interest by researchers towards improving their analytical performance while maintaining their robust assay platform. Commercially, visual and optical detection strategies dominate, but it is especially the research on integrating electrochemical (EC) approaches that may have a chance to significantly improve an LFA's performance that is needed in order to detect analytes reliably at lower concentrations than currently possible. In fact, EC-LFAs offer advantages in terms of quantitative determination, low-cost, high sensitivity, and even simple, label-free strategies. Here, the various configurations of EC-LFAs published are summarized and critically evaluated. In short, most of them rely on applying conventional transducers, e.g., screen-printed electrode, to ensure reliability of the assay, and additional advances are afforded by the beneficial features of nanomaterials. It is predicted that these will be further implemented in EC-LFAs as high-performance transducers. Considering the low cost of point-of-care devices, it becomes even more important to also identify strategies that efficiently integrate nanomaterials into EC-LFAs in a high-throughput manner while maintaining their favorable analytical performance. Graphical abstract.Entities:
Keywords: Electrochemical detection; Electrochemical transducers; Lateral flow assay; Nanofibers; Point-of-care devices
Year: 2021 PMID: 33913001 PMCID: PMC8410735 DOI: 10.1007/s00216-021-03301-y
Source DB: PubMed Journal: Anal Bioanal Chem ISSN: 1618-2642 Impact factor: 4.142
Fig. 1Timeline of the exemplary developments of LFA starting in 1984 with the first clearblue home pregnancy test (clearblue.com), which continued with two important patents: solid-phase assay with visual readout [4] and capillary immunoassay [5], then the first pregnancy test based on a lateral flow test (clearblue.com), leading to the first patent on LFA using colloidal gold [6]. The development continued with the first EC-LFA and first use of liposomes [7], followed by first use of carbon nanoparticles (CNP) [8], then liposomes entrapping dyes [9] and use of aptamers in LFA [10]. Further research led to DNA hybridization detection-based LFA using enzyme as a tracer [11], implementation of DNAzyme for metal ion detection [12], use of CNT [13], QDs [14], and MNP [15], achieving multiplex detection [16]. Further improvements focused on tracer strategies, like metal ligand complexes [17], cellulose nanobeads [18], and the coupling to a smartphone [19]. In the past few years, the research has been focused on further developing labels like Pt-nanoparticles (PtNP) [20], the use of Ag staining for amplification [21], combining LFA with SERS [22], implementing nanofibers (NF) [23], using different shapes of colloidal gold [24], using different nanoparticles (NP) like IrO2 [25] or CuO [26], and integrating electrodes for electrochemiluminescence (ECL) [27]. The texts shown in blue, green, purple, and red represent the development focusing on assay format, signal tracer, detection technique, and recognition element, respectively. Figures reprinted from (i) [7], (iv) [19], (v) [23] with permission from Elsevier. Figures reprinted from (ii) [10] and (vi) [27] with permission from John Wiley and Sons. Figure (iii) reprinted from [12] with permission from Royal Society of Chemistry
Fig. 2The components of an LFA
LFA-based electrochemical detection with their analytical performance
| Analytes | Electrode type | Method | Signal tracer | Electrode assemble strategy | LOD | Linear range | Reference |
|---|---|---|---|---|---|---|---|
| Clenbuterol | PANI@GO/ITO | EIS | – | Strip between the electrodes | 0.12 ppb | 0.12–58 ppb | [ |
| Organophosphorus pesticide | SPE | SWV | Acetylcholinesterase | Test zone cut with cutter embedded in plastic case | 0.02 nM | 0.05–10 nM | [ |
| Alpha-fetoprotein | SPE | SWV | HRP | Electrode under test zone | 0.5 ng/mL | 1–100 ng/mL | [ |
| PSA | SPE | SWV | CdSe@ZnS QD | Electrode under test zone | 0.02 ng/mL | 0.05–4 ng/mL | [ |
| hCG | SPE | SWASV | Bi3+ | Electrode under test zone | 1 mIU | 0–70 mIU | [ |
| Lead and cadmium | SPCE | SWV | – | Electrode over the test zone | 7 and 11 ppb | 10 to 100 ppb | [ |
| Trichloropyridinol | SPCE | SWV | HRP | Test zone cut with cutter embedded in plastic case | 0.1 ng/mL | 0.1–100 ng/mL | [ |
| 8-OHdG | CNT paper | CA | – | Electrode over the test zone | 3.11 ng/mL | 0–150 ng/mL | [ |
| Myeloperoxidase | SPE | CA | MBs (separation) and HRP | SPE printed on the membrane | 0.18 ng/mL | 0.25–8 ng/mL | [ |
| Testosterone | Gold electrodes made by lithography | CA | HRP | Test zone cut | 1 ng/mL | 1–625 ng/mL | [ |
| Troponin I | ITO | CC | Gal and An-GP | Electrode over the test zone | 0.1 pg/mL | 0.1 pg/mL–100 ng/mL | [ |
| PSA | Interdigitated-SCPE | Capacitance | Urease | Electrode over the test zone | 1 ng/mL | 0–30 ng/mL | [ |
| Cardiac troponin T | SPE | CV | HRP | Electrode under test zone | 0.15 ng/ml | 0–700 ng/mL | [ |
| Dengue NS1 protein | SPGE | CV | TEMPO-tagged AuNP | Electrode under test zone | 50 ng/mL | 0–1000 ng/mL | [ |
| 8-OHdG and PSA | – | Glucose meter | Invertase | Test and control zone cut | 0.23 and 1.26 ng/mL | 0.1–100 and 1–100 ng/mL | [ |
| Hg(II) ions | SPE | SWV | HRP | Test zone cut | 30 pg/mL | 0.1–200 ng/mL | [ |
MBs magnetic beads, Gal galactosidase, AN-GP 4-amino-1-naphthyl β-d-galactopyranoside, AN 4-amino-1-naphthol, PANI@GO/ITO polyaniline@graphene oxide/indium tin oxide, 8-OHdG 8-hydroxy-20-deoxyguanosine, PSA prostate-specific antigen, SWASV square wave anodic stripping voltammetry
Fig. 3Scheme of existing principles to integrate electrodes into LFS: A electrodes underneath NC with the different electrode orientations (i and ii), B electrodes placed above the NC with the electroactive surface facing downwards, C NC membrane positioned in between the stacked electrodes in a two-electrode configuration, D cutting of the test zone and performing electrochemical measurement off-strip, and E types of electrodes and modifications which were demonstrated in developing EC-LFA
Fig. 4Representative exemplary EC-LFAs with various electrode configuration integrated into LFS as well as assay platforms. A ITO electrode-coated glass plates assembled onto LFS (b) and detection principle (a), reprinted from [82] with permission from Royal Society of Chemistry. B The CNT conductive paper integrated immunostrip (a) and photograph of actual device adapted from [79] with permission from Royal Society of Chemistry. C The single-step quantitative EC-LFS using glucose oxidase (GOx) as signal tracer (a), and components of LFS at the top and side views (b) adapted with permission from [88]. Copyright (2017) Japan Society for Analytical Chemistry. D Integrating cutter into an LFS holder for precisely cutting the test line adapted from [73] with permission from American Chemical Society. E Internal screen-printed electrodes on LFS reprinted from [80] with permission from John Wiley and Sons